Observation of the neuroprotective efficacy of vitamin K in a streptozocin‐induced diabetes model in chick embryos
Open Access
- 30 November 2023
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 38 (1) , e23609
Abstract
Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia due to insulin deficiency and/or resistance. Vitamin K (VK) is a group of fat‐soluble molecules, including naturally occurring vitamin K1 (phylloquinone). vitamin K2 (menaquinone), and synthetic vitamin K3 (menadione). Beyond coagulation, the health benefits of VK have been described to play different roles in both physiological and pathological processes such as inflammation, energy metabolism, neuroprotection, cellular growth, and survival. It was aimed to observe the antioxidant and/or neuroprotective activity of vitamin K1 in our model of chick embryo diabetic neuropathy (DN) induced by streptozotocin (STZ). Ninety White Leghorn, fertile and 0‐day‐old SPF (specific pathogen‐free) eggs (57 ± 4 gr) were used in the study. Chick embryo blood brain tissues were taken for biochemical evaluation. Plasma insulin and glucose levels were measured. In addition, brain tissue total antioxidant level (TAS), total oxidant level (TOS), malondialdehyde (MDA), and vascular endothelial growth factor (VEGF) levels were measured. Plasma glucose levels were higher in the STZ‐treated groups and lower in the treatment groups. Plasma insulin levels were observed to be higher in STZ groups in groups treated with high VK. Low TAS, high MDA, TOS, and VEGF levels were recorded in brain tissue STZ groups. Low VEGF, TOS, and MDA levels were recorded in the group treated with the highest VK, while high TAS levels were observed. In our STZ‐induced chick embryo diabetic neuropathy model, we observed that VK1 reduced oxidant damage by showing antioxidant properties or by modulating antioxidant enzymes.Keywords
This publication has 45 references indexed in Scilit:
- Antioxidant Strategies in the Management of Diabetic NeuropathyBioMed Research International, 2015
- New Insights for Oxidative Stress and Diabetes MellitusOxidative Medicine and Cellular Longevity, 2015
- Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasisExperimental Eye Research, 2014
- Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesisJournal of Lipid Research, 2014
- Retinal Not Systemic Oxidative and Inflammatory Stress Correlated with VEGF Expression in Rodent Models of Insulin Resistance and DiabetesInvestigative Ophthalmology & Visual Science, 2012
- Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brainBMC Complementary and Alternative Medicine, 2012
- Plaque neovascularization: defense mechanisms, betrayal, or a war in progressAnnals of the New York Academy of Sciences, 2012
- Dietary Phylloquinone and Menaquinones Intakes and Risk of Type 2 DiabetesDiabetes Care, 2010
- VEGF gene polymorphism association with diabetic neuropathyMolecular Biology Reports, 2010
- Animal models of diabetes mellitusDiabetic Medicine, 2005